|
answer text |
<p>Officials at the Department and Public Health England have regular discussions
with manufacturers on a range of issues. This has included discussion with Seqirus,
the company that has produced the new adjuvanted trivalent flu vaccine (aTIV).</p><p>
</p><p>Officials have had no discussions with general practitioner representatives
or patient groups on the aTIV.</p><p> </p><p>Officials also attend meetings of the
Joint Committee on Vaccination and Immunisation, which includes a lay member.</p><p><strong>
</strong></p>
|
|